• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内修复术与开放手术治疗破裂性腹主动脉瘤的疗效和安全性:一项对比研究。

Efficacy and safety of endovascular repair versus open surgery for ruptured abdominal aortic aneurysm: a comparative study.

作者信息

Huang Mingkui, Tang Yinhe

机构信息

Department of Vascular Surgery, Taizhou Central Hospital (Taizhou University Hospital) Taizhou 318001, Zhejiang, China.

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Wenzhou Medical College Wenzhou 325000, Zhejiang, China.

出版信息

Am J Cancer Res. 2025 Mar 15;15(3):1234-1247. doi: 10.62347/NYJT8307. eCollection 2025.

DOI:10.62347/NYJT8307
PMID:40226464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11982736/
Abstract

OBJECTIVE

Ruptured abdominal aortic aneurysm (rAAA) is a life-threatening condition with high mortality. This study compared the efficacy and safety of open surgical repair (OSR) and endovascular aortic repair (EVAR) in the treatment of rAAA.

METHODS

A retrospective analysis of clinical data was conducted for 232 rAAA patients treated at Taizhou Central Hospital and the First Affiliated Hospital of Wenzhou Medical College. Patients were divided into two groups based on surgical methods: OSR group (n=84) and EVAR group (n=148). Perioperative indicators, perioperative complication rates, and 1-year mortality rates were compared. Patients were further divided into a survival group (n=160) and a death group (n=72) based on their 1-year survival status, and the risk factors affecting the prognosis of rAAA patients were analyzed. Postoperative pain was evaluated using the Visual Analog Scale (VAS), Verbal Rating Scale (VRS), and Present Pain Intensity (PPI). Serum levels of C-reactive protein (CRP) and white blood cells (WBC), pro-inflammatory interleukins (IL-1α, IL-6, IL-8), and tumor necrosis factor-α (TNF-α) were measured before and after treatment using enzyme-linked immunosorbent assays (ELISA).

RESULTS

Compared with the OSR group, the EVAR group had significantly shorter surgical time, less intraoperative bleeding (IOB) and intraoperative blood transfusion volume, reduced intraoperative infusion volume, shorter fasting and first walk time, and shorter ICU and hospital days. The incidence of complications in the EVAR group was significantly lower than that in the OSR group (<0.05). Pain scores (VAS, VRS, and PPI) and serum levels of CRP, WBC, IL-1α, IL-6, IL-8, and TNF-α were significantly lower in the EVAR group than those in the OSR group (all <0.05). There was no significant difference in perioperative mortality between the two groups (28.95% vs. 11.80%, >0.05). However, the 1-year mortality rate was significantly lower in the EVAR group (38.1% vs. 27.0%, P<0.05). Multivariate logistic regression analysis identified Alb<40 g/L (=0.004), Cre≥1.5 mg/dL (=0.007), urea nitrogen ≥25 mg/dL (=0.001), ALT≥40 U/L (=0.002), and treatment method (OSR) (=0.024) as independent risk factors for poor postoperative prognosis.

CONCLUSION

EVAR demonstrates significant advantages over OSR in reducing surgical trauma, decreasing postoperative complications, alleviating pain and inflammatory responses, and improving postoperative survival rates.

摘要

目的

腹主动脉瘤破裂(rAAA)是一种危及生命的疾病,死亡率很高。本研究比较了开放手术修复(OSR)和血管腔内主动脉修复(EVAR)治疗rAAA的疗效和安全性。

方法

对在台州中心医院和温州医科大学附属第一医院接受治疗的232例rAAA患者的临床资料进行回顾性分析。根据手术方法将患者分为两组:OSR组(n = 84)和EVAR组(n = 148)。比较围手术期指标、围手术期并发症发生率和1年死亡率。根据患者1年生存状态进一步分为生存组(n = 160)和死亡组(n = 72),并分析影响rAAA患者预后的危险因素。使用视觉模拟评分法(VAS)、语言评定量表(VRS)和目前疼痛强度(PPI)评估术后疼痛。采用酶联免疫吸附测定(ELISA)法测定治疗前后血清C反应蛋白(CRP)、白细胞(WBC)、促炎细胞因子(IL-1α、IL-6、IL-8)和肿瘤坏死因子-α(TNF-α)水平。

结果

与OSR组相比,EVAR组手术时间明显缩短,术中出血量(IOB)和术中输血量减少,术中输液量减少,禁食和首次下床时间缩短,ICU住院时间和住院天数缩短。EVAR组并发症发生率明显低于OSR组(<0.05)。EVAR组疼痛评分(VAS、VRS和PPI)以及血清CRP、WBC、IL-1α、IL-6、IL-8和TNF-α水平均明显低于OSR组(均<0.05)。两组围手术期死亡率无显著差异(28.95%对11.80%,>0.05)。然而,EVAR组1年死亡率明显较低(38.1%对27.0%,P<0.05)。多因素logistic回归分析确定Alb<40 g/L(=0.004)、Cre≥1.5 mg/dL(=0.007)、尿素氮≥25 mg/dL(=0.001)、ALT≥40 U/L(=0.002)和治疗方法(OSR)(=0.024)为术后预后不良的独立危险因素。

结论

在减少手术创伤、降低术后并发症、减轻疼痛和炎症反应以及提高术后生存率方面EVAR显示出比OSR显著优势。

相似文献

1
Efficacy and safety of endovascular repair versus open surgery for ruptured abdominal aortic aneurysm: a comparative study.血管内修复术与开放手术治疗破裂性腹主动脉瘤的疗效和安全性:一项对比研究。
Am J Cancer Res. 2025 Mar 15;15(3):1234-1247. doi: 10.62347/NYJT8307. eCollection 2025.
2
One-Year Outcomes after Ruptured Abdominal Aortic Aneurysms Repair: Is Endovascular Aortic Repair the Best Choice? A Single-Center Experience.腹主动脉瘤破裂修复术后一年的结果:血管内主动脉修复是最佳选择吗?单中心经验。
Ann Vasc Surg. 2018 Nov;53:63-69. doi: 10.1016/j.avsg.2018.04.004. Epub 2018 Jun 6.
3
Hospital Volume of Elective Abdominal Aortic Aneurysm Repair as a Predictor of Mortality After Ruptured Abdominal Aortic Aneurysm Repair.择期腹主动脉瘤修复手术的医院容量作为破裂性腹主动脉瘤修复术后死亡率的预测指标。
Eur J Vasc Endovasc Surg. 2024 Jul;68(1):30-38. doi: 10.1016/j.ejvs.2024.02.034. Epub 2024 Feb 29.
4
Treatment Outcomes of Patients With Ruptured Abdominal Aortic Aneurysms.破裂性腹主动脉瘤患者的治疗结果。
J Korean Med Sci. 2023 Oct 9;38(39):e321. doi: 10.3346/jkms.2023.38.e321.
5
Population-based long-term outcomes of open versus endovascular aortic repair of ruptured abdominal aortic aneurysms.基于人群的开放手术与血管内修复治疗破裂腹主动脉瘤的长期结局比较。
J Vasc Surg. 2020 Jun;71(6):1867-1878.e8. doi: 10.1016/j.jvs.2019.06.212. Epub 2020 Feb 19.
6
Nationwide Outcomes of Octogenarians Following Open or Endovascular Management After Ruptured Abdominal Aortic Aneurysms.八旬老人破裂性腹主动脉瘤开放或血管内治疗后的全国性结局。
J Endovasc Ther. 2023 Jun;30(3):419-432. doi: 10.1177/15266028221083460. Epub 2022 Mar 21.
7
Endovascular Versus Open Repair for Ruptured Abdominal Aortic Aneurysms in a Chinese Population.中国人群中破裂腹主动脉瘤的血管内修复与开放修复对比
Ann Vasc Surg. 2016 Oct;36:74-84. doi: 10.1016/j.avsg.2016.03.006. Epub 2016 Jul 13.
8
Evaluating the Effectiveness and Clinical Outcomes of Endovascular Aneurysm Repair-First Approach for Ruptured Abdominal Aortic Aneurysm in Japan.评估日本腹主动脉瘤破裂患者采用血管内动脉瘤修复优先治疗方法的有效性和临床结果。
J Endovasc Ther. 2024 Apr 24:15266028241248337. doi: 10.1177/15266028241248337.
9
A comparative study on the medium-long term results of endovascular repair and open surgical repair in the management of ruptured abdominal aortic aneurysms.血管内修复与开放手术修复治疗破裂腹主动脉瘤的中远期效果比较研究。
Chin Med J (Engl). 2013;126(24):4771-9.
10
The association of ruptured abdominal aortic aneurysm diameter with mortality in the International Consortium of Vascular Registries.国际血管登记研究协会中破裂腹主动脉瘤直径与死亡率的相关性。
J Vasc Surg. 2024 Apr;79(4):748-754.e2. doi: 10.1016/j.jvs.2023.11.033. Epub 2023 Nov 25.

本文引用的文献

1
Clinical Application of n-Butyl-2- Cyanoacrylate (NBCA) in the Transarterial Embolization for Type I/II Endoleak During and After EVAR Surgery.正丁基-2-氰基丙烯酸酯(NBCA)在腔内血管修复术(EVAR)手术期间及术后经动脉栓塞治疗Ⅰ/Ⅱ型内漏中的临床应用
Ann Vasc Surg. 2025 Jan;110(Pt A):439-446. doi: 10.1016/j.avsg.2024.09.060. Epub 2024 Oct 18.
2
The Association between Plasma Proinflammatory Cytokine Concentrations and Endoleak after Endovascular Aortic Aneurysm Repair.
Ann Vasc Surg. 2025 Jan;110(Pt A):244-254. doi: 10.1016/j.avsg.2024.09.043. Epub 2024 Sep 27.
3
The Impact of Intra-Operative Heparin on Thromboembolism and Death in a Matched Cohort of Patients with a Ruptured Abdominal Aortic Aneurysm.术中肝素对腹主动脉瘤破裂患者匹配队列中血栓栓塞和死亡的影响
EJVES Vasc Forum. 2023 Nov 24;61:20-26. doi: 10.1016/j.ejvsvf.2023.11.004. eCollection 2024.
4
Modern management of ruptured abdominal aortic aneurysm.腹主动脉瘤破裂的现代管理。
Front Cardiovasc Med. 2023 Dec 12;10:1323465. doi: 10.3389/fcvm.2023.1323465. eCollection 2023.
5
Treatment Outcomes of Patients With Ruptured Abdominal Aortic Aneurysms.破裂性腹主动脉瘤患者的治疗结果。
J Korean Med Sci. 2023 Oct 9;38(39):e321. doi: 10.3346/jkms.2023.38.e321.
6
A protocol-based treatment for ruptured abdominal aortic aneurysm contributed to improving aorta-related mortality: a retrospective cohort study.基于方案的破裂性腹主动脉瘤治疗有助于降低主动脉相关死亡率:一项回顾性队列研究。
BMC Cardiovasc Disord. 2023 Sep 1;23(1):436. doi: 10.1186/s12872-023-03473-8.
7
Preoperative Immature Neutrophils Predict Clinical Outcomes in Patients with Uncomplicated Type-B Aortic Dissection After Thoracic Endovascular Aortic Repair.术前未成熟中性粒细胞可预测单纯B型主动脉夹层患者胸主动脉腔内修复术后的临床结局。
Int J Gen Med. 2023 Aug 21;16:3637-3644. doi: 10.2147/IJGM.S414567. eCollection 2023.
8
Novel pharmacological approaches in abdominal aortic aneurysm.新型腹主动脉瘤药理学治疗方法。
Clin Sci (Lond). 2023 Aug 14;137(15):1167-1194. doi: 10.1042/CS20220795.
9
Percutaneous treatment of abdominal aortic aneurysm and aortic valve stenosis with 'staged' EVAR and TAVR: a case series.经皮治疗腹主动脉瘤和主动脉瓣狭窄的“分期”EVAR 和 TAVR:病例系列。
J Cardiothorac Surg. 2023 Jul 13;18(1):231. doi: 10.1186/s13019-023-02338-7.
10
The Challenge of Endoleaks in Endovascular Aneurysm Repair (EVAR): A Review of Their Types and Management.血管内动脉瘤修复术(EVAR)中内漏的挑战:类型与处理综述
Cureus. 2023 May 31;15(5):e39775. doi: 10.7759/cureus.39775. eCollection 2023 May.